Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Gains from Investment Securities (2020 - 2024)

INVO Fertility has reported Gains from Investment Securities over the past 5 years, most recently at $50000.0 for Q2 2024.

  • Quarterly Gains from Investment Securities rose 2031.29% to $50000.0 in Q2 2024 from the year-ago period, while the trailing twelve-month figure was -$511663.0 through Dec 2024, changed N/A year-over-year, with the annual reading at -$511663.0 for FY2024, N/A changed from the prior year.
  • Gains from Investment Securities was $50000.0 for Q2 2024 at INVO Fertility, up from -$561663.0 in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $1.5 million in Q2 2022 and troughed at -$561663.0 in Q1 2024.
  • The 5-year median for Gains from Investment Securities is $56509.0 (2020), against an average of $489646.7.
  • The largest YoY upside for Gains from Investment Securities was 2031.29% in 2024 against a maximum downside of 70307.88% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at $56509.0 in 2020, then tumbled by 95.76% to $2395.0 in 2021, then skyrocketed by 317.54% to $10000.0 in 2022, then rose by 9.73% to $10973.0 in 2023, then surged by 355.66% to $50000.0 in 2024.
  • Per Business Quant, the three most recent readings for IVF's Gains from Investment Securities are $50000.0 (Q2 2024), -$561663.0 (Q1 2024), and $10973.0 (Q3 2023).